DLEU7-AS1 promotes renal cell cancer by silencing the miR-26a-5p/coronin-3 axis

Xinjun Wang, Chen Lin, Ran Xu, Si Li, Guangcheng LuoClinical 2022 · DOI

Abstract

Long non-coding RNAs (lncRNAs) have been implicated in the progression and development of many types of cancer by interacting with RNA, DNA and proteins, including DLEU7-AS1. However, the function of DLEU7-AS1 in renal cell cancer (RCC) remains unclear. In this study, two <i>in silico</i> prediction algorithms were used to discover the potential target of miR-26a-5p, which was determined to be a tumor suppressor gene, possibly DLEU7-AS1, through the downregulation of coronin-3 in RCC. Thus, we hypothesized that DLEU7-AS1 promotes RCC by silencing the miR-26a-5p/coronin-3 axis. To test our hypothesis, we confirmed that DLEU7-AS1 directly targets miR-26a-5p using the pmirGLO dual-luciferase reporter assay. Next, we observed that DLEU7-AS1 expression was markedly upregulated in RCC samples and inversely correlated with clinical prognosis and miR-26a-5p levels. Knockdown of DLEU7-AS1 significantly suppressed the growth and metastasis of RCC cells <i>in vitro</i> and attenuated tumor growth <i>in vivo</i>. Interestingly, exogenous expression of coronin-3 or miR-26a-5p inhibitor treatment almost completely rescued the DLEU7-AS1 knockdown-induced inhibitory effects on cell proliferation, migration and invasion. In conclusion, our data demonstrate that DLEU7-AS1 is an oncogene in RCC capable of regulating the growth and metastasis of RCC by silencing the miR-26a-5p/coronin-3 axis, suggesting that DLEU7-AS1 can be employed as a potential therapeutic target and prognostic biomarker for RCC.
BibTeX
@inproceedings{wang2022dleu,
  author = {Xinjun Wang and Chen Lin and Ran Xu and Si Li and Guangcheng Luo},
  title = {{DLEU7-AS1 promotes renal cell cancer by silencing the miR-26a-5p/coronin-3 axis}},
  booktitle = {Clinical},
  year = {2022},
  doi = {10.1093/ckj/sfac061},
}

Loading related content...

Figure